The future of the global microcrystalline cellulose market looks promising with opportunities in the pharmaceutical, personal care & cosmetic, food & beverage, and paint & coating markets.
- Within the source category, wood-based is expected to witness higher growth over the forecast period due to renewable origin preferred in wood-based microcrystalline cellulose.
- Within the application category, pharmaceutical is expected to witness the highest growth over the forecast period due to expanding pharmaceutical manufacturing requiring MCC excipients.
- In terms of regions, North America is expected to witness the highest growth over the forecast period due to established pharmaceutical industry and continuous excipient demand.
Emerging Trends in Microcrystalline Cellulose Market
The microcrystalline cellulose (MCC) market is evolving from supplying excipients in high-volume markets to high-value markets. Between 2025 and 2027, pharmaceuticals will continue to dominate this market, and the use of food and nutraceuticals, as well as other industrial applications, will expand the market. According to Lucintel, this will be driven by expansion as manufacturers increase capacity and shorten supply chains.- Sustainability: The EU PPWR entered into force in February 2025, increasing the need to reduce non-recyclable inputs. MCC’s cellulose origin supports lower-impact formulations, and the pressure will be evident in customer purchasing decisions through 2030, as customers will require manufacturers to use raw materials with verified feedstock and carbon data.
- Digital Manufacturing: Digital controls for moisture and particle size are dramatically improving the consistency of MCC. Between 2025 and 2027, we expect several continuous manufacturing projects to apply real-time release, resulting in grades that span roughly 20 to 180 micrometers. Digital control and improved consistency will result in decreased qualification costs. The current focus on digital control will drive improvements in consistency through 2030.
- Functional Products: We expect the use of basic fillers to be displaced by functional products. Between 2025 and 2027 we expect a sustained launch of nutraceuticals and the continued evolution of the food industry to create additional demand for products that have a cleaner label. Product functions will allow for improved margins and increase the role MCC plays beyond tablets through 2030.
- Regional Supply Chain Diversification: While the dependence on a single source of supply for pulp remains, we expect the continued growth of the pharma industry in India and Southeast Asia to drive the need for local qualified MCC. This will also drive the use of dual supply routes. Through 2030, suppliers with multiple certified routes will be most favorable.
- Circular Economy: Programs to recover cellulose and purify it with less waste are the focus of a growing number of company sustainability programs to improve material efficiency. Through 2030, programs to improve circular processing will gain traction as decreasing manufacturing loss becomes critical.
Recent Developments in the Microcrystalline Cellulose Market
The Market for Microcrystalline Cellulose is Expected To Grow Through 2025-2027, as Drug Manufacturers Increase Capacity for Excipient Production and as Food Companies Work To Reformulate To Produce Cleaner Label Products. in Lucintel’s Opinion, The Market Will Grow, but The More Noteworthy Changes Will Be Commercial: The ability to qualify and trace products and supply from specific regions will become important factors in purchasing decisions, in addition to price.- Increased Capacity: Roquette announced a 50 million Euro investment (April 2025) for their Pharmaceutical Excipient facility in France to help improve their supply resilience and capacity, to allow them to fulfill higher volume contracts and reduce their reliance on single site sourcing over the next 3-5 years.
- Technology Launch: IFF launched Avicel grade for use in direct compression tablets, with improved flow and compact ability (Sept 2025). The launch is significant because generic drug manufacturers are seeking simplified formulations that reduce processing steps and costs.
- Strategic Collaboration: DFE Pharma expanded its partnership with regional drug manufacturers through a technical service program for excipient and formulation selection (Feb 2025). These partnerships shift the focus of competition from commodities to application and formulation in various pharmaceutical markets.
- Production Localization: A major Indian pharmaceutical company commissioned an additional solid dose capacity of approximately $120 million (Jan 2026), potentially increasing demand for pharmaceutical grade microcrystalline cellulose in the region. Given the freight and logistics challenges in the industry, regional sourcing will gain preference of manufacturers for both product and process validation.
- Regulatory Approval: The U.S. FDA approved more than 60 abbreviated new drug applications (ANDAs) that contained microcrystalline cellulose in the first half of 2025 (Jun 2025). Continuous approvals of generics will create a base demand for the product. Tighter documentation will reward suppliers that have continuously functional and verified grades.
Strategic Growth Opportunities in the Microcrystalline Cellulose Market
Between 2024 and 2026, the microcrystalline cellulose market is moving beyond pharmaceutical excipients as manufacturers reformulate for cleaner labels and oral-dose efficiency while seeking regional supply security. Lucintel’s perspective points to applications where consistent functionality commands a premium.- Premium Pharmaceutical Excipients: Formulators need low-bioburden, directly compressible grades for oral solid dosage products. Novo Nordisk reported DKK 78.1 billion in first-quarter sales (April 2025), supporting demand for MCC with predictable compaction over the next three to five years.
- Nutraceutical Delivery Systems: Nutraceutical tablets need neutral, stable bulking agents for high-load formulations. U.S. supplement sales reached $69.3 billion in 2024 (October 2025, CRN); customized MCC grades should gain orders as brands expand compressed formats over the next three to five years.
- Sustainable Formulation Inputs: Brand owners are replacing petrochemical-derived ingredients with renewable cellulose. Unilever reported a 29% reduction in virgin plastic packaging versus its 2019 baseline (February 2025); traceable MCC should gain specification wins in food and personal care over the next three to five years.
- South Asian Expansion: India’s pharmaceutical market was valued at $55 billion in 2024 and is projected to reach $130 billion by 2030 (April 2025, IBEF). Local qualification and regional warehousing can turn production into recurring MCC revenue over the next three to five years.
- Continuous Manufacturing Services: Direct compression and continuous processing require tighter particle-size control and excipient specifications. FDA’s CDER approved 50 novel drugs in 2024 (January 2025); co-development services can lift MCC margins as manufacturers seek consistent performance over the next three to five years.
Microcrystalline Cellulose Market Drivers and Challenges
The microcrystalline cellulose market is driven by several demand factors from the pharmaceutical, food, nutraceutical, and personal care industries, in addition to advances in processing, sustainability and regulatory requirements. According to Lucintel, the key growth drivers are product innovation and manufacturing. However, other factors such as volatility of raw materials, costs of qualification, substitution risks and changing obligations to comply with the laws continue to shape the investment and competitive strategies.The factors responsible for driving this market include:
- Pharmaceutical Industry: Microcrystalline cellulose is widely used in pharmaceutical and allied industries as a filler, binder, disintegrant and a flow aid in tableting. Being a reliable excipient, it supports the formation of consistent and reliable dosage forms. With the increased consumption of generic pharmaceuticals, over the counter medications, and nutraceutical tablets, the demand for microcrystalline cellulose has also increased. In January 2025, the U.S. Food and Drug Administration’s (FDA) annual report stated that the agency approved 50 new drugs in the year 2024, illustrating the increasing pace of pharmaceutical industry activity. In the next three to five years, the ageing population will increase the demand for pharmaceuticals. With this, chronic disease treatments will also increase, and generics will also flood the markets. Reliable and consistent microcrystalline cellulose suppliers will be of great help to the manufacturers.
- Food and Nutraceutical Industry: Use of microcrystalline cellulose in the food and nutraceutical industry as an anti-caking agent, texturizer, fat-replacer, and a bulking agent has increased. It also helps in formulation of low calorie foods, and other stable formulations. In October 2025, food and beverage companies continued positive outlook in the high-protein and reduced-sugar food and beverage segments. In the next three to five years, the demand for convenience and ‘on the go’ foods will increase, and along with this, nutrition supplements will also increase. Thus, the food industry will focus on ingredients that fulfill multiple roles and offer processing reliability.
- Process Technology Improvements: Improvements in purification, hydrolysis, drying, milling, surface modification and control of particle size have improved consistency of microcrystalline cellulose. Given these advances, cellulose producers have been able to address specific needs of customers by producing customized grades. Ranging from direct compression, wet granulation, to suspension stabilization, extrusion and specialized foods and cosmetics, the variety of cellulose grades has considerably increased. In June 2025, the latest update on Good Manufacturing Practices for pharmaceuticals promoted use of Process Analytical Technology and the need to better control critical material attributes, thus motivating excipient suppliers to provide tighter specifications and more extensive characterization data. It is expected that in the next 3 to 5 years improvements in process technology will enable the development of higher-end grades, reduce batch-to-batch variability, and facilitate formulation of lower-dose pharmaceutical and other products, thus expanding the market beyond conventional grades of cellulose.
- Sustainability and Renewable Feed Stocks: Microcrystalline cellulose, being bio-based, recyclable and lower impact than many formulation ingredients, appeals to manufacturers to decrease their environmental footprint. There is increasing demand for microcrystalline cellulose as manufacturers reduce their use of petroleum-based additives and as sustainability concerns of consumers and clients increase. The European Union’s Packaging and Packaging Waste Regulation, which entered into force in February 2025, lays the foundation to implement broader policies to reduce the impacts of packaging and encourages greater circularity in packaging. While the policy does not mandate the use of microcrystalline cellulose, it establishes a broad policy framework and increases demand for the use of renewable raw materials. In the next 3 to 5 years, greater focus will be placed on sustainability, procurement and processing by manufacturers, thereby, influencing consumer preference.
- Manufacturing Efficiency & Costs: Microcrystalline cellulose offers favorable functionality at relatively low use levels. This enables formulators to improve tablet hardness and flow, increase stability and reduce production time without having to use numerous bulky excipients. Further reductions in manufacturing costs can be achieved by larger production facilities, improved recovery systems and automation. In April 2025, the continuous and high-speed table tiers initiative was further advanced, where consistent flow of excipients and compressibility of the charge are critical to the operation of the equipment. Cost-conscious food and drug producers will favor excipients with lower downtime and simplified formulations in the next 3-5 years, while excipient suppliers with integrated cellulose processing will have a reliability and scale advantage.
The challenges facing this market include:
- Raw Material and Price Volatility: The markets relies on a number of raw materials such as wood pulp and cotton linters, and are thus exposed to raw material price volatility and supply disruptions. In March 2025, the Food and Agriculture Organization’s Food Price Index was at 118.9 points, signaling the volatility in the broader agricultural and commodity systems that affect logistics and operating costs. Price volatility in the next 3-5 years will promote regional sourcing, supplier diversification, and inventory and contract level risk management. Shorter-cycle manufacturers may face challenges offsetting costs increases and losing price competitiveness.
- Regulatory and Qualification Complexity: There are several requirements for microcrystalline cellulose in the pharmaceutical, food, cosmetic, and nutraceutical fields in major jurisdictions. Customers require more detailed impurity profiles, allergen declarations, microbial limits and testing, residual solvents, product traceability, and change control documentation. In February 2025, the EU’s Packaging and Packaging Waste Regulation, which contains additional requirements for different product and packaging categories, came into force. This increases the existing compliance burden for manufacturers operating across different markets. In the next 3 to 5 years, higher regulatory scrutiny and quality requirements will extend approval cycles and further favor suppliers with best-in-class quality and documentation systems and local/regional compliance know-how.
- Substitution and Performance Trade-Offs: Advances in technology and consumer preferences may cause disruption in the marketplace. For example, customers may require components to be disintegrating, moisture protective, and/or to release at specific rates. In September 2025, the requirement for multifunctional excipient systems continued to rise, mainly due to interest in components that incorporate binding, disintegrating, and/or flow control in a single excipient.
List of Microcrystalline Cellulose Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microcrystalline cellulose market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the microcrystalline cellulose market companies profiled in this report include:
- Roquette Frères
- JRS PHARMA
- Asahi Kasei Corporation
- Apollo Scientific
- SEPPIC
- Ankit Pulps
- GODAVARI BIOREFINERIES
- International Flavors & Fragrances
- DFE Pharma
- Fengchen Group
Microcrystalline Cellulose Market by Segment
The study includes a forecast for the global microcrystalline cellulose market by source, form, application, and region.Source [Value ($B) from 2019 to 2035]:
- Wood-based
- Non-wood-based
Form [Value ($B) from 2019 to 2035]:
- Powder
- Liquid
Application [Value ($B) from 2019 to 2035]:
- Pharmaceutical
- Personal Care & Cosmetics
- Food & Beverages
- Paints & Coatings
- Others
Region [Value ($B) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Microcrystalline Cellulose Market
Microcrystalline cellulose is a major pharmaceutical and food excipient, and supply chains are being restructured due to qualification requirements and regional manufacturing. Between 2025 and 2027, producers emphasize GMP conformity and the resilience and purity of their capacities. As per Lucintel’s latest market study, competitive positioning will be largely determined by investments.- United States: Acquisition: Roquette completed the acquisition of IFF’s Pharma Solutions business for approximately $2.85 billion in June 2025, and thus integrated Avicel microcrystalline cellulose into its excipient portfolio. The larger scale can strengthen investment, qualification, and supply for US drug manufacturers.
- China: Local manufacturing: In March 2025, Anhui Sunhere released corporate information disclosing it had developed more than 100 excipient specifications in 2024 and reported RMB1.1 billion in revenue, illustrating the scale of China’s qualified excipient manufacturers. This development is relevant as China’s regulatory framework continues to evolve to encourage greater domestic manufacturing of excipients and reduce reliance on imported excipients.
- Germany: Compliance: In 2025, JRS PHARMA continued to specify their VIVAPUR microcrystalline cellulose GMP manufacturing site as Rosenberg, supported by their parent group which employs more than 2,500 people. This is relevant as European customers typically opt for excipient suppliers located within the EU and prioritize audited and traceable manufacturing facilities in long-term agreements.
- India: Expanding capacity: As of September 2025, Sigachi Industries’ investor documents indicated microcrystalline-cellulose manufacturing capacity of about 36,000 MT in its Indian sites. This is important as it demonstrates Sigachi’s further investment in India’s pharma excipient manufacturing sector and helps meet the local demands of formulation companies and pharma exports.
- Japan: Projects and procurement: Asahi Kasei’s continued investment in the Mizushima site, Ceolus, through 2026, is relevant as increased production from Japan can meet the demand for advanced tablet manufacturing across the region.
Features of the Global Microcrystalline Cellulose Market
- Market Size Estimates: microcrystalline cellulose market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: microcrystalline cellulose market size by source, form, application, and region in terms of value ($B).
- Regional Analysis: microcrystalline cellulose market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different sources, forms, applications, and regions for the microcrystalline cellulose market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microcrystalline cellulose market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the microcrystalline cellulose market by source (wood-based and non-wood-based), form (powder and liquid), application (pharmaceutical, personal care & cosmetics, food & beverages, paints & coatings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Roquette Frères
- JRS PHARMA
- Asahi Kasei Corporation
- Apollo Scientific
- SEPPIC
- Ankit Pulps
- GODAVARI BIOREFINERIES
- International Flavors & Fragrances
- DFE Pharma
- Fengchen Group
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

LOADING...

